Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:32 AM
Ignite Modification Date:
2025-12-25 @ 1:32 AM
NCT ID:
NCT07151794
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 65 years
* Diagnosed with solid tumor malignancy
* Planned to undergo at least two cycles of adjuvant, neoadjuvant, or metastatic chemotherapy
* Clinically stable condition
* Provided written informed consent
Exclusion Criteria:
* Presence of hematological malignancies
* Concurrent hormonal therapy, targeted therapy, immunotherapy, or radiotherapy
* Acute infection or advanced organ failure (cardiac, hepatic, renal)
* Cognitive or psychiatric impairment preventing test participation
* Prior treatment with G-CSF
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
65 Years
Study:
NCT07151794
Study Brief:
Protocol Section:
NCT07151794